Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

PLAU and SerpinB2 affect cell death differently in various forms of leprosy and could be targets for new treatments.

Recognizing diverse presentations of folliculotropic mycosis fungoides is crucial to avoid diagnostic errors.

Netherton syndrome has two subtypes with shared immune traits but different allergic and immune responses, suggesting targeted treatments.

Topical corticosteroids can help treat severe alopecia areata when other treatments fail.

Prednisone may cause multiple skin nodules in lupus patients.

The 2012 criteria are better for diagnosing atypical lupus cases.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Resident memory T cells and necroptosis may drive fibrosis in eosinophilic fasciitis and morphea.

A lotion with 5% minoxidil boosts the immune response in guinea pigs.

Cortisone tapering may help improve severe myasthenia gravis and alopecia areata after thymectomy.

Stopping methotrexate might reverse lymphoma-like conditions in some patients.

Methylprednisolone pulse therapy works best for recent and specific types of severe alopecia areata.

A man was diagnosed with a rare form of lupus after showing unique skin symptoms that responded well to treatment.

Scalp biopsies are crucial for diagnosing hair loss causes in cutaneous lymphoma patients.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

A skin condition called pyodermatitis vegetans was found in a patient with multiple myeloma for the first time.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Moderate immune responses help hair growth, while excessive responses slow it down.

A woman with lupus had blood cell destruction, treated successfully with medication.

Some people with severe, long-lasting baldness responded well to a specific combination treatment.

Murine cytomegalovirus does not cause alopecia areata in these mice.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Targeting specific T cells may help treat alopecia areata.

Skin issues from chronic graft-versus-host disease greatly affect daily life, needing teamwork between blood and skin doctors.

Skin and mucous symptoms are key for diagnosing autoimmune connective tissue diseases.

HPV 60 may cause cysts and warts on the face, not just hands and feet.